WS10.06Pre-clinical validation of GY971, a new anti-inflammatory agent targeting Nuclear Factor kappa B (NF-kB)
Author:
C. Tupini,S. Fagnani,G. Raso,A. Chilin,G. Marzaro,A. Tamanini,N. Pedemonte,V. Capurro,A. Bragonzi,G. Cabrini,I. Lampronti
Publication:
Journal of Cystic Fibrosis
Copyright © 2025 Published by Elsevier B.V.